Follow the accumulating evidence and observations that shape our view of health policy and obesity
December 10, 2024 — A pitched battle is underway. The fight is for equitable access to obesity medicines that can be life-changing for people living with obesity. Right now, we have a bit of a stalemate and money is the sticking point. So when Andrew Ross Sorkin put the question of greed, economics, and health to the CEO of […]
December 9, 2024 — Eat healthy and get your exercise. It is a straightforward framework for dealing with obesity. But that simple prescription of diet and exercise for preventing obesity overlooks a critical factor – the prolonged sitting time very often required by work and school. A recent study of data from young adult twins showed that sitting time […]
December 8, 2024 — A man was murdered this week in a manner of cold determination. As of this writing, we do not know why. But because he was the CEO of UnitedHealthcare – America’s largest health insurer – many people are interpreting this murder as an expression of rage and contempt for the health insurance industry. Some are […]
December 7, 2024 — The concept of turning food into medicine mildly repels us. But telling us chocolate is medicine simply goes over the line. Yet here comes a study in the BMJ, spinning off headlines about dark chocolate as a “bittersweet remedy for diabetes risk.” Milk chocolate? Nope. In fact, the authors of this observational study say milk […]
December 6, 2024 — The market for precision nutrition advice is more than six billion dollars today and estimated to double by the end of this decade. Sales of continuous glucose monitoring devices are on their way to $20 billion within three years. But a new study this week in the American Journal of Clinical Nutrition suggests that the […]
December 5, 2024 — Bragging rights. Yesterday, Lilly claimed them for its obesity medicine, the Zepbound brand of tirzepatide. The company announced topline results from a head-to-head trial of tirzepatide vs semaglutide for weight loss in persons with obesity or overweight and at least one obesity-related complication. It should be no surprise that tirzepatide won this narrowly-defined contest. In […]
December 4, 2024 — Why can’t they just go away? When compounded GLP-1 medicines started showing up two years ago, they seemed like a temporary distraction. In The New Yorker, Jia Tolentino described a dubious concoction of semaglutide she obtained from a compounding pharmacy for herself to mix and inject. “No thanks,” we wrote, hoping this sketchy business would […]
December 3, 2024 — “This seems like a landmark paper in my books and a call from the other side of the energy balance equation. We seem built to be a highly physically active species, not sedentary office workers and couch dwellers.” With these words, Professor Emeritus Jennie Brand-Miller seized our attention today. She was writing about a new […]
December 2, 2024 — The drumbeat is growing louder. “Public health policies to reduce ultra-processed food intake cannot wait.” These words from Mathilde Touvier summed up her presentation of evidence on these foods from epidemiologic and public health studies at Imperial College London last week. She opened six hours of scholars, politicians, and advocates presenting a compelling case. Clearly, […]
December 1, 2024 — One of the more colorful nominations the U.S. president-elect has made is certainly, from our perspective, Robert F. Kennedy Jr for Secretary of Health and Human Services. Described by Donald Trump as a “radical left lunatic” earlier this year, Kennedy is now getting the nod from Trump to “go wild on health and dramatically shake […]
